UofT Libraries is getting a new library services platform in January 2021.
Learn more about the change.

Search Articles

X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (8959) 8959
Newsletter (1400) 1400
Newspaper Article (76) 76
Magazine Article (12) 12
Dissertation (8) 8
Book Chapter (6) 6
Reference (4) 4
Transcript (2) 2
Book / eBook (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
deoxycholic acid (6714) 6714
science & technology (4280) 4280
life sciences & biomedicine (3789) 3789
animals (3420) 3420
humans (3142) 3142
male (2272) 2272
deoxycholic acid - pharmacology (1833) 1833
biological and medical sciences (1594) 1594
female (1495) 1495
rats (1357) 1357
research (1317) 1317
analysis (1262) 1262
physiological aspects (1000) 1000
medical sciences (976) 976
bile acids and salts - metabolism (962) 962
bile acids (917) 917
biochemistry & molecular biology (854) 854
mice (837) 837
liver (833) 833
adult (768) 768
chemistry (765) 765
bile (764) 764
middle aged (749) 749
pharmacology & pharmacy (732) 732
fundamental and applied biological sciences. psychology (695) 695
physical sciences (677) 677
kinetics (649) 649
abridged index medicus (642) 642
deoxycholic acid - analogs & derivatives (635) 635
cholesterol (566) 566
deoxycholic acid - metabolism (540) 540
gastroenterology & hepatology (537) 537
liver - metabolism (497) 497
acids (491) 491
pharmacology. drug treatments (490) 490
deoxycholic acid - chemistry (470) 470
aged (432) 432
solubility (424) 424
hydrogen-ion concentration (420) 420
physical fitness (411) 411
microbiology (401) 401
liver diseases (399) 399
bile acid (398) 398
time factors (398) 398
medical research (395) 395
proteins (388) 388
health aspects (373) 373
medicine, experimental (371) 371
protein binding (360) 360
mass spectrometry (355) 355
gene expression (349) 349
microbiota (343) 343
research article (343) 343
deoxycholic acid - administration & dosage (341) 341
bile acids and salts - pharmacology (338) 338
enzymes (337) 337
lipids (332) 332
cholesterol - metabolism (324) 324
cytochrome p-450 (316) 316
drug combinations (316) 316
cell biology (311) 311
cholic acid (310) 310
metabolites (299) 299
care and treatment (296) 296
digestive system (296) 296
universities and colleges (292) 292
rabbits (287) 287
in vitro techniques (284) 284
cholestasis (283) 283
bile acids and salts - analysis (280) 280
metabolism (280) 280
ursodeoxycholic acid - therapeutic use (279) 279
cancer (278) 278
deoxycholic acid - therapeutic use (273) 273
rats, sprague-dawley (273) 273
dose-response relationship, drug (270) 270
surgery (268) 268
liver - drug effects (267) 267
bile acids and salts - blood (262) 262
molecular weight (262) 262
fatty acids (257) 257
biophysics (256) 256
bile acids and salts - chemistry (252) 252
cattle (250) 250
glucose (250) 250
apoptosis (248) 248
diet (248) 248
micelles (245) 245
cells, cultured (240) 240
rodents (235) 235
methods (231) 231
obesity (231) 231
rats, inbred strains (229) 229
cell line (227) 227
chenodeoxycholic acid - pharmacology (223) 223
endocrinology & metabolism (223) 223
mice, inbred c57bl (221) 221
chenodeoxycholic acid - metabolism (219) 219
genes (216) 216
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (10141) 10141
Japanese (183) 183
German (90) 90
Russian (67) 67
French (61) 61
Chinese (44) 44
Spanish (30) 30
Italian (27) 27
Korean (13) 13
Portuguese (10) 10
Polish (7) 7
Ukrainian (6) 6
Czech (3) 3
Dutch (2) 2
Serbian (2) 2
Bulgarian (1) 1
Danish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal Article
Journal of hepatology, ISSN 0168-8278, 2015, Volume 62, Issue 6, pp. 1398 - 1404
Gastroenterology and Hepatology | 3-hydroxy-3-methylglutaryl-CoA reductase | Stearoyl-CoA desaturase | Non-alcoholic fatty liver disease | Lipogenesis | FGF19 | 3-hydroxy-3-methylglutaryl- CoA reductase | Gastroenterology & Hepatology | Life Sciences & Biomedicine | Science & Technology | Ursodeoxycholic Acid - administration & dosage | Oleic Acid - metabolism | Bile Acids and Salts - biosynthesis | Humans | Liver - metabolism | Bile Acids and Salts - metabolism | Non-alcoholic Fatty Liver Disease - metabolism | Intra-Abdominal Fat - metabolism | Obesity, Morbid - drug therapy | Non-alcoholic Fatty Liver Disease - drug therapy | Ursodeoxycholic Acid - pharmacology | Stearoyl-CoA Desaturase - biosynthesis | Liver - drug effects | Receptors, Cytoplasmic and Nuclear - antagonists & inhibitors | Lipid Metabolism - drug effects | Intra-Abdominal Fat - drug effects | Obesity, Morbid - metabolism | Physiological aspects | Obesity | Ursodiol | Deoxycholic acid | Index Medicus | BAs, bile acids | nCEH, neutral cholesterol ester hydrolase | ApoB, apolipoprotein B | LDLR, low density lipoprotein receptor | FGF19, fibroblast growth factor 19 | VLDL, very low density lipoproteins | ABC, ATP-binding cassette | TGs, triglycerides | NAFLD, non-alcoholic fatty liver disease | OA, oleic acid | C4, 7α-hydroxy-4-cholesten-3-one | SHP, small heterodimer partner | SREBP1c, sterol regulatory element-binding protein-1c | CA, cholic acid | PA, palmitic acid | FATP1, fatty acid transport protein 1 | UDCA, ursodeoxycholic acid | FAs, fatty acides | HMGCR, 3-hydroxy-3-methylglutaryl-CoA reductase | vWAT, visceral white adipose tissue | SCD, stearoyl-Coa desaturase | CYP7A1, cholesterol 7α-hydroxylase | NASH, non-alcoholic steatohepatitis | FXR, farnesoid X receptor | CDCA, chenodeoxycholic acid | MA, myristic acid | FASN, fatty acid synthase | MTTP, microsomal triglyceride transfer protein | SA, stearic acid | NONALCOHOLIC | FATTY LIVER-DISEASE | NUCLEAR RECEPTOR | CHOLESTEROL-METABOLISM | TRANSPORT | Endokrinologi och diabetes | FEEDBACK-REGULATION | STEATOHEPATITIS | PLACEBO-CONTROLLED TRIAL | COA DESATURASE | EXPRESSION | Endocrinology and Diabetes | ADIPOSE-TISSUE
Journal Article
Journal of hepatology, ISSN 0168-8278, 2012, Volume 58, Issue 1, pp. 155 - 168
Gastroenterology and Hepatology | Gallstones | Liver cancer | Bile acids | Fatty liver disease | Cholestasis | Liver regeneration | Gastroenterology & Hepatology | Life Sciences & Biomedicine | Science & Technology | Animals | Carrier Proteins - metabolism | Cholestasis - metabolism | Membrane Glycoproteins - metabolism | Humans | Liver - metabolism | Bile Acids and Salts - metabolism | Liver Diseases - metabolism | Liver Regeneration - physiology | Receptors, Cytoplasmic and Nuclear - metabolism | Drug resistance in microorganisms | Corticosteroids | Glucagon | Calcifediol | Ursodiol | Deoxycholic acid | Epidermal growth factor | Vitamin D | Physiological aspects | Fibroblast growth factors | Alfacalcidol | Index Medicus | IBABP (FABP6, ILBP), intestinal bile acid-binding protein, fatty acid-binding protein 6 | PFIC, progressive familial intrahepatic cholestasis | TNFα, tumor necrosis factor α | 3 (human) | SRC2, p160 steroid receptor coactivator | NAFLD, non-alcoholic fatty liver disease | BA, bile acid | bile acid receptor | 8, cholesterol efflux pump, ATP-binding cassette, subfamily G, member 5 | UDCA, ursodeoxycholic acid | LRH-1 (NR5A2), liver receptor homolog-1 | LCA, lithocholic acid | LXRα (NR1H3), liver X receptor alpha | PPARγ (NR1C3), peroxisome proliferator-activated receptor gamma | OSTαβ, organic solute transporter alpha | ABCG5 | AMPK, AMP activated protein kinase | NASH, non-alcoholic steatohepatitis | SHP (NR0B2), short heterodimer partner | OATP1A2 (SLCO1A2, OATP1, OATP-A, SLC21A3), solute carrier organic anion transporter family, member 1A2 | EGFR, epidermal growth factor receptor | IL6, interleukin 6 | TGR5, G protein-coupled bile acid receptor | PH, partial hepatectomy | AE2, anion exchanger 2 | PSC, primary sclerosing cholangitis | OATP1B1 (SLCO1B1, OATP2, OATP-C, SLC21A6), solute carrier organic anion transporter family, member 1B1 | RARα (NR1B1), retinoic acid receptor alpha | GLP-1, glucagon like peptide 1 | VDR (NR1I1), vitamin D receptor. Please note that for the convenience of better readability and clarity, abbreviations for transporters and nuclear receptors were capitalized throughout this article when symbols were identical for human and rodents | MRP2 (ABCC2), multidrug resistance-associated protein 2, ATP-binding cassette, subfamily C, member 2 | NTCP (SLC10A1), sodium | CAR (NR1I3), constitutive androstane receptor | taurocholate cotransporting polypeptide, solute carrier family 10, member 1 | PPARα (NR1C1), peroxisome proliferator-activated receptor alpha | Review | GR (NR3C1), glucocorticoid receptor | Bile acids, Cholestasis, Fatty liver disease, Gallstones, Liver regeneration, Liver cancer | 19, fibroblast growth factor 15 | Mdr2 | ICP, intrahepatic cholestasis of pregnancy | BRIC, benign recurrent intrahepatic cholestasis | OATP1B3 (SLCO1B3, OATP8, SLC21A8), solute carrier organic anion transporter family, member 1B3 | MRP3 (ABCC3), multidrug resistance-associated protein 3, ATP-binding cassette, subfamily C, member 3 | beta | MDR1 (ABCB1), p-glycoprotein, ATP-binding cassette, subfamily B, member 1 | norUDCA, norursodeoxycholic acid | 6-ECDCA, 6-ethylchenodeoxycholic acid | FXR (NR1H4), farnesoid X receptor | BCRP (ABCG2), breast cancer resistance protein, ATP-binding cassette, subfamily G, member 2 | HNF4α (NR2A1), hepatocyte nuclear factor 4 alpha | PBC, primary biliary cirrhosis | MDR3 (ABCB4), multidrug resistance protein 2 (rodents) | HNF1α, hepatocyte nuclear factor 1 alpha | NR, nuclear receptor | FGF15 | RXRα (NR2B1), retinoid X receptor alpha | PXR (NR1I2), pregnane X receptor | BSEP (ABCB11), bile salt export pump | HCC, hepatocellular carcinoma | MRP4 (ABCC4), multidrug resistance-associated protein 4, ATP-binding cassette, subfamily C, member 4 | TPN, total parenteral nutrition
Journal Article